Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 29, 2025 08:00 ET | Source: Therini Bio, Inc.

Therini Bio Announces First Patient Dosed in Phase 1b Trial of THN391 in Alzheimer’s Disease

Therini Bio announced the dosing of the first patient in their Phase 1b trial evaluating THN391 in Alzheimer's Disease
May 14, 2025 10:00 ET | Source: Therini Bio, Inc.

Therini Bio Raises Additional $39M Series A Financing to Advance Clinical Development of Neurodegenerative Disease Pipeline

Therini Bio raised a $39M Series A financing, bringing the Series A total to $75M, from top-tier investors to commence THN391 Ph 1b AD and DME studies
May 15, 2023 01:15 ET | Source: Novartis Pharma AG

New Sandoz Board of Directors appointed

Novartis Board of Directors approves the recommendation of Sandoz Chairman-designate for the future Sandoz Board of Directors, to start preparatory work in June, followed by formal constitution in H2...
October 05, 2022 09:45 ET | Source: The Vilcek Foundation

Science Crossing Borders: Celebrating the Contributions of Immigrant Scientists

NEW YORK, Oct. 05, 2022 (GLOBE NEWSWIRE) -- They come from around the world—born in Taiwan, India, Lebanon, Israel, Romania, and Russia, among other places—but they all call the United States home....
September 01, 2022 01:00 ET | Source: Novartis Pharma AG

Novartis appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.D., steps down from the Executive Committee of Novartis

After seven years as President of NIBR and a member of the ECN, Dr. Bradner will pursue a next chapter of scientific contribution and leadership outside of NovartisBuilding on NIBR foundation, Dr....
November 14, 2019 09:08 ET | Source: SEngine Precision Medicine

SEngine Precision Medicine Names Surgical Oncologist and Cancer Care Advocate Dr. Astrid Margossian as Chief Medical Officer

SEATTLE, Washington, Nov. 14, 2019 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, an oncology pioneer accelerating cancer drug discovery through its proprietary diagnostic platform known as The...